GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets

Genome-wide Association Study
DOI: 10.1101/2023.10.04.23296543 Publication Date: 2023-10-06T00:13:07Z
ABSTRACT
Psoriasis is a common, debilitating immune-mediated skin disease. Genetic studies have identified biological mechanisms of psoriasis risk, including those targeted by effective therapies. However, the genetic liability to not fully explained variation at robustly risk loci. To move towards saturation map susceptibility we meta-analysed 18 GWAS comprising 36,466 cases and 458,078 controls 109 distinct loci, 45 that been previously reported. These include variants loci in which therapeutic targets IL17RA AHR are encoded, deleterious coding supporting potential new drug (including STAP2, CPVL POU2F3). We conducted transcriptome-wide association study identify regulatory effects cross-referenced these against single cell expression profiles psoriasis-affected skin, highlighting roles for transcriptional regulation haematopoietic development epigenetic modulation interferon signalling pathobiology.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (86)
CITATIONS (15)